"Glioma" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21)
| Descriptor ID |
D005910
|
| MeSH Number(s) |
C04.557.465.625.600.380 C04.557.470.670.380 C04.557.580.625.600.380
|
| Concept/Terms |
Glioma- Glioma
- Gliomas
- Glial Cell Tumors
- Glial Cell Tumor
- Tumor, Glial Cell
- Tumors, Glial Cell
Mixed Glioma- Mixed Glioma
- Glioma, Mixed
- Gliomas, Mixed
- Mixed Gliomas
Malignant Glioma- Malignant Glioma
- Glioma, Malignant
- Gliomas, Malignant
- Malignant Gliomas
|
Below are MeSH descriptors whose meaning is more general than "Glioma".
Below are MeSH descriptors whose meaning is more specific than "Glioma".
This graph shows the total number of publications written about "Glioma" by people in this website by year, and whether "Glioma" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 3 | 0 | 3 |
| 1996 | 4 | 2 | 6 |
| 1997 | 1 | 0 | 1 |
| 1998 | 2 | 0 | 2 |
| 1999 | 0 | 3 | 3 |
| 2000 | 4 | 2 | 6 |
| 2001 | 1 | 0 | 1 |
| 2002 | 2 | 2 | 4 |
| 2003 | 3 | 0 | 3 |
| 2004 | 2 | 1 | 3 |
| 2005 | 5 | 0 | 5 |
| 2006 | 5 | 1 | 6 |
| 2007 | 6 | 0 | 6 |
| 2008 | 13 | 0 | 13 |
| 2009 | 10 | 1 | 11 |
| 2010 | 22 | 1 | 23 |
| 2011 | 16 | 3 | 19 |
| 2012 | 10 | 0 | 10 |
| 2013 | 14 | 2 | 16 |
| 2014 | 10 | 1 | 11 |
| 2015 | 11 | 0 | 11 |
| 2016 | 11 | 1 | 12 |
| 2017 | 13 | 1 | 14 |
| 2018 | 11 | 1 | 12 |
| 2019 | 13 | 1 | 14 |
| 2020 | 7 | 1 | 8 |
| 2021 | 12 | 0 | 12 |
| 2022 | 16 | 1 | 17 |
| 2023 | 14 | 0 | 14 |
| 2024 | 8 | 2 | 10 |
| 2025 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Glioma" by people in Profiles.
-
Chimeric antigen receptor T-cell therapy in patients with malignant glioma-From neuroimmunology to clinical trial design considerations. Neuro Oncol. 2025 Feb 10; 27(2):352-368.
-
Clinical Characteristics and Outcomes of Central Nervous System Tumors Harboring NTRK Gene Fusions. Clin Cancer Res. 2025 Feb 03; 31(3):561-572.
-
Clinical and Imaging Features of Head and Neck Metastasis of High-Grade Glioma: A Single-Center Case Series. AJNR Am J Neuroradiol. 2025 Jan 08; 46(1):160-165.
-
Targeted radionuclide therapy for gliomas: Emerging clinical trial landscape. Neuro Oncol. 2024 Dec 09; 26(Supplement_9):S208-S214.
-
Immune landscape of isocitrate dehydrogenase-stratified primary and recurrent human gliomas. Neuro Oncol. 2024 Dec 05; 26(12):2239-2255.
-
Tumor Expression of CD83 Reduces Glioma Progression and Is Associated with Reduced Immunosuppression. Cancer Res Commun. 2024 12 01; 4(12):3209-3223.
-
Oncolytic Virotherapies and Adjuvant Gut Microbiome Therapeutics to Enhance Efficacy Against Malignant Gliomas. Viruses. 2024 Nov 14; 16(11).
-
Fc-enhanced anti-CTLA-4, anti-PD-1, doxorubicin, and ultrasound-mediated blood-brain barrier opening: A novel combinatorial immunotherapy regimen for gliomas. Neuro Oncol. 2024 Nov 04; 26(11):2044-2060.
-
Analysis of DNA Methylation in Gliomas: Assessment of Preanalytical Variables. Lab Invest. 2024 Dec; 104(12):102160.
-
The biological significance of tumor grade, age, enhancement, and extent of resection in IDH-mutant gliomas: How should they inform treatment decisions in the era of IDH inhibitors? Neuro Oncol. 2024 Oct 03; 26(10):1805-1822.